Belite Bio Inc
NASDAQ:BLTE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Belite Bio Inc
NASDAQ:BLTE
|
US |
|
G
|
George Weston Ltd
OTC:WNGRF
|
CA |
|
Beam Communications Holdings Ltd
ASX:BCC
|
AU |
|
A
|
Avolta AG
XMUN:D2J
|
CH |
|
Scanfil Oyj
F:S0A
|
FI |
|
G
|
GI Innovation Inc
KOSDAQ:358570
|
KR |
|
Bank BTPN Syariah Tbk PT
IDX:BTPS
|
ID |
|
Polymetals Resources Ltd
ASX:POL
|
AU |
|
Toyota Motor Corp
F:TOM
|
JP |
|
E
|
eSang Networks Co Ltd
KOSDAQ:080010
|
KR |
|
Imperial Oil Ltd
TSX:IMO
|
CA |
|
N
|
Nova Empire PCL
SET:NOVA
|
TH |
|
Y
|
Yara International ASA
XMUN:IU2
|
NO |
|
S
|
SC Asset Corporation PCL
SET:SC
|
TH |
|
Schneider Electric SE
PAR:SU
|
FR |
|
D
|
Daiwa Securities Group Inc
OTC:DSECF
|
JP |
|
H
|
Hill and Smith PLC
F:7HL
|
UK |
|
I
|
Imperial Oil Ltd
F:IMP
|
CA |
|
Adastra Holdings Ltd
F:D2E0
|
CA |
|
Valora Effekten Handel AG
F:VEH
|
DE |
|
Hellenic Telecommunications Organization SA
F:OTES
|
GR |
|
S
|
Siamgas and Petrochemicals PCL
SET:SGP
|
TH |
|
Capella Minerals Ltd
F:N7D
|
CA |
|
C
|
Charter Communications Inc
F:CQD
|
US |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Belite Bio Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Belite Bio Does
Belite Bio is a clinical-stage drug developer focused on eye diseases that damage the retina and can lead to vision loss. Its main work is developing oral medicines for conditions such as Stargardt disease and dry age-related macular degeneration, where patients need long-term treatment to slow or prevent further damage.
- Headquarters
- United States of America US
- Employees
- 41
- IPO date
- Apr 29, 2022